Initial results from phase I dose escalation trial of CAN1012 in patients with solid tumor malignancies

Authors

H Yu
Brendan Curti, ProvidenceFollow
Will Redmond, ProvidenceFollow
See full list of authors in comments

Document Type

Abstract

Publication Date

11-1-2023

Keywords

oregon; chiles

Clinical Institute

Cancer

Department

Oncology

Comments

Yu H, Yao H, Li N, Wang S, Curti B, Massimini G, Hu M-H, Redmond WL, Lou R, Geng W, Wang S, Zhang M, Chen R, Qin B, Mao J, Wang S, Song E. SITC Annual Meeting; November 1-5; San Diego, CA. 2023;11(Suppl 1): 763.

Recommended Citation

Yu, H; Curti, Brendan; Redmond, Will; and See full list of authors in comments, "Initial results from phase I dose escalation trial of CAN1012 in patients with solid tumor malignancies" (2023). Articles, Abstracts, and Reports. 8353.
https://digitalcommons.providence.org/publications/8353